CVR: 40958169
Secondary names: Innovision ApS, PulmoTrace ApS, InnoCC ApS
COSMED Nordic ApS is facing significant financial challenges, with consistent losses over the past five years. Revenue peaked in 2023 at 9,333,884 DKK but has since declined to 7,422,341 DKK in 2025, while losses have deepened, reaching -2,917,543 DKK. The company's equity position has deteriorated, moving from -2,823,349 DKK in 2021 to 1,658,268 DKK in 2025, indicating ongoing financial instability. With a focus on manufacturing medical and therapeutic equipment, COSMED Nordic's declining revenue and persistent negative profit margins raise concerns about its sustainability and competitive position within the industry.
AI-generated summary
Selskabets formål er at drive forskning, udvikling og salg af medikoteknikse apparater og hermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 7.4 mio. | -2.9 mio. | 6.9 mio. | 1.7 mio. | 4 | |
Compared to 54 companies in Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr
Comparison is based on industry median values
Companies in the same industry and area
CVR 41572760
CVR 31826063
CVR 32931235
CVR 34901791
CVR 32999328
companydata.dk